May 3, 2018
Using new data to personalize stroke prevention
By Advancing the Science contributor
By Peter Noseworthy, MD, with Xiaoxi Yao, PhD, Mayo Clinic The irregular heartbeat known as atrial fibrillation (AF) is a common and serious heart disease impacting about 3 million Americans today. Patients with AF experience palpitations, shortness of breath and dizziness, which can make simple activities such as playing with grandchildren or walking upstairs challenging. […]
Tags: anticoagulant, atrial fibrillation, Center for the Science of Health Care Delivery, OptumLabs, Peter Noseworthy, Xiaoxi Yao
December 6, 2017
Research Roundup–November 2017
The Research Roundup is a compilation of research news releases from Mayo Clinic during the last month. You can read the brief summaries in this post, or click through for the full news release and related content. Thanks for visiting Advancing the Science! Research finds hot flashes, night sweats connected to obstructive sleep apnea risk […]
Tags: anticoagulant, atrial fibrillation, cardiology, Center for Individualized Medicine, clinical trials, J. William Charboneau, Joseph Grande, menopause, MOG antibody, neurology, prostate cancer, research education
June 19, 2017
1 in 6 taking blood-thinning drugs may not be getting right dose, research shows
A growing number of Americans are expected to develop atrial fibrillation, a common heart condition characterized by an irregular and rapid heart rate. But almost 1 in 6 of the millions of Americans on new blood-thinning medications for a-fib may not be getting the right dose, Mayo Clinic research finds.
Tags: anticoagulant, atrial fibrillation, Center for the Science of Health Care Delivery, kidney disease, OptumLabs, Peter Noseworthy, stroke, Xiaoxi Yao
May 3, 2016
Determining which drug works better for which patients “Our findings definitely point toward important age-related risk that merits consideration when doctors are making treatment recommendations,” says lead author Neena Abraham, M.D. To the average TV viewer, it may seem like new drugs flood the marketplace daily. However, from the 1950s until just recently, warfarin was […]
Tags: anticoagulant, atrial fibrillation, cardiology, Center for the Science of Health Care Delivery, FDA, Neena Abraham
January 5, 2016
Did your patient have cardiac ablation? Don’t stop the anticoagulant!
By Advancing the Science contributor
Peter Noseworthy, M.D., is a cardiac electrophysiologist at Mayo Clinic, and a Kern Health Care Delivery Scholar in the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. ________________________________________________________________________ As a cardiac electrophysiologist, I am interested in helping to improve health and quality of life for my patients […]
Tags: anticoagulant, atrial fibrillation, cardiology, Center for the Science of Health Care Delivery, OptumLabs, Peter Noseworthy, stroke